19-54783763-A-G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_014218.3(KIR2DL1):​c.997A>G​(p.Thr333Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.149 in 1,604,402 control chromosomes in the GnomAD database, including 2,106 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.15 ( 254 hom., cov: 33)
Exomes 𝑓: 0.15 ( 1852 hom. )

Consequence

KIR2DL1
NM_014218.3 missense

Scores

1
17

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.983

Publications

10 publications found
Variant links:
Genes affected
KIR2DL1 (HGNC:6329): (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1) Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002367258).
BP6
Variant 19-54783763-A-G is Benign according to our data. Variant chr19-54783763-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 3060390.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 254 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIR2DL1NM_014218.3 linkc.997A>G p.Thr333Ala missense_variant Exon 8 of 8 ENST00000336077.11 NP_055033.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIR2DL1ENST00000336077.11 linkc.997A>G p.Thr333Ala missense_variant Exon 8 of 8 1 NM_014218.3 ENSP00000336769.5
KIR2DL1ENST00000291633.7 linkc.1075A>G p.Thr359Ala missense_variant Exon 9 of 9 1 ENSP00000291633.7
ENSG00000215765ENST00000400864.3 linkn.72-2700A>G intron_variant Intron 2 of 5 5

Frequencies

GnomAD3 genomes
AF:
0.153
AC:
23003
AN:
150592
Hom.:
252
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.163
Gnomad AMI
AF:
0.115
Gnomad AMR
AF:
0.142
Gnomad ASJ
AF:
0.184
Gnomad EAS
AF:
0.0293
Gnomad SAS
AF:
0.250
Gnomad FIN
AF:
0.146
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.151
Gnomad OTH
AF:
0.162
GnomAD2 exomes
AF:
0.000267
AC:
33
AN:
123566
AF XY:
0.000183
show subpopulations
Gnomad AFR exome
AF:
0.00257
Gnomad AMR exome
AF:
0.000259
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000135
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000583
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.148
AC:
215318
AN:
1453690
Hom.:
1852
Cov.:
71
AF XY:
0.153
AC XY:
110547
AN XY:
723368
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.163
AC:
5387
AN:
32980
American (AMR)
AF:
0.101
AC:
4499
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.195
AC:
5078
AN:
26090
East Asian (EAS)
AF:
0.0206
AC:
819
AN:
39674
South Asian (SAS)
AF:
0.258
AC:
22112
AN:
85768
European-Finnish (FIN)
AF:
0.145
AC:
7712
AN:
53344
Middle Eastern (MID)
AF:
0.230
AC:
1322
AN:
5738
European-Non Finnish (NFE)
AF:
0.144
AC:
158623
AN:
1105334
Other (OTH)
AF:
0.163
AC:
9766
AN:
60078
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.354
Heterozygous variant carriers
0
12693
25387
38080
50774
63467
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5988
11976
17964
23952
29940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.153
AC:
23023
AN:
150712
Hom.:
254
Cov.:
33
AF XY:
0.155
AC XY:
11417
AN XY:
73620
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.163
AC:
6654
AN:
40922
American (AMR)
AF:
0.142
AC:
2148
AN:
15180
Ashkenazi Jewish (ASJ)
AF:
0.184
AC:
635
AN:
3442
East Asian (EAS)
AF:
0.0292
AC:
151
AN:
5178
South Asian (SAS)
AF:
0.251
AC:
1184
AN:
4722
European-Finnish (FIN)
AF:
0.146
AC:
1525
AN:
10440
Middle Eastern (MID)
AF:
0.221
AC:
64
AN:
290
European-Non Finnish (NFE)
AF:
0.151
AC:
10209
AN:
67530
Other (OTH)
AF:
0.166
AC:
349
AN:
2102
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.398
Heterozygous variant carriers
0
966
1932
2897
3863
4829
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0750
Hom.:
8
ExAC
AF:
0.0000896
AC:
9

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

KIR2DL1-related disorder Benign:1
Aug 09, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.1
DANN
Benign
0.57
DEOGEN2
Benign
0.016
T;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.00059
N
LIST_S2
Benign
0.0
.;.
M_CAP
Benign
0.00041
T
MetaRNN
Benign
0.0024
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.0
.;.
PhyloP100
-0.98
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.68
N;N
REVEL
Benign
0.010
Sift
Uncertain
0.013
D;D
Sift4G
Benign
0.71
T;T
Vest4
0.034
ClinPred
0.0032
T
GERP RS
-1.8
gMVP
0.026
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2756923; hg19: chr19-55295215; COSMIC: COSV108083096; API